Search
Kalaris Therapeutics Inc
KLRSAdd to Watchlist
4.750USD
+0.220+4.86%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
109.21MMarket Cap
LossP/E TTM
Kalaris Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Kalaris Therapeutics Inc is 6.28, ranking 346 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.03, which is -99.86% below the recent high of -0.01 and -10.95% above the recent low of -6.70.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.